A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies

por Pi-Estopiñan, Franciscary, Pérez, María Teresa, Fraga, Anitza, Bergado, Gretchen, Díaz, Geidy D., Orosa, Ivette, Díaz, Marianniz, Solozábal, Joaquín Antonio, Rodríguez, Laura Marta, Garcia-Rivera, Dagmar, Macías, Consuelo, Jerez, Yanet, Casadesús, Ana V., Fernández-Marrero, Briandy, Bermúdez, Ernesto, Plasencia, Claudia A., Sánchez, Belinda, Hernández, Tays
Publicado 2022

Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens

por Boggiano-Ayo, Tammy, Palacios-Oliva, Julio, Lozada-Chang, Sumlai, Relova-Hernandez, Ernesto, Gomez-Perez, Jose, Oliva, Gonzalo, Hernandez, Lourdes, Bueno-Soler, Alexi, Montes de Oca, Daidee, Mora, Osvaldo, Machado-Santisteban, Roberto, Perez-Martinez, Dayana, Perez-Masson, Beatriz, Cabrera Infante, Yanelys, Calzadilla-Rosado, Lisandra, Ramirez, Yaima, Aymed-Garcia, Judey, Ruiz-Ramirez, Ingrid, Romero, Yamile, Gomez, Tania, Espinosa, Luis A., Gonzalez, Luis Javier, Cabrales, Annia, Guirola, Osmany, de la Luz, Kathya Rashida, Pi-Estopiñan, Franciscary, Sanchez-Ramirez, Belinda, Garcia-Rivera, Dagmar, Valdes-Balbin, Yuri, Rojas, Gertrudis, Leon-Monzon, Kalet, Ojito-Magaz, Eduardo, Hardy, Eugenio
Publicado 2023

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity

por Pérez-Rodríguez, Sonia, de la Caridad Rodríguez-González, Meiby, Ochoa-Azze, Rolando, Climent-Ruiz, Yanet, Alberto González-Delgado, Carlos, Paredes-Moreno, Beatriz, Valenzuela-Silva, Carmen, Rodríguez-Noda, Laura, Perez-Nicado, Rocmira, González-Mugica, Raúl, Martínez-Pérez, Marisel, Sánchez-Ramírez, Belinda, Hernández-García, Tays, Díaz-Machado, Alina, Tamayo-Rodríguez, Maura, Martín-Trujillo, Alis, Rubino-Moreno, Jorman, Suárez-Batista, Anamary, Dubed-Echevarría, Marta, Teresa Pérez-Guevara, María, Amoroto-Roig, Mayté, Chappi-Estévez, Yanet, Bergado-Báez, Gretchen, Pi-Estopiñán, Franciscary, Chen, Guang-Wu, Valdés-Balbín, Yury, García-Rivera, Dagmar, Verez-Bencomo, Vicente
Publicado 2022

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

por Eugenia-Toledo-Romaní, María, Verdecia-Sánchez, Leslyhana, Rodríguez-González, Meiby, Rodríguez-Noda, Laura, Valenzuela-Silva, Carmen, Paredes-Moreno, Beatriz, Sánchez-Ramírez, Belinda, Pérez-Nicado, Rocmira, González-Mugica, Raul, Hernández-García, Tays, Bergado-Baez, Gretchen, Pi-Estopiñán, Franciscary, Cruz-Sui, Otto, Fraga-Quintero, Anitza, García-Montero, Majela, Palenzuela-Díaz, Ariel, Baró-Román, Gerardo, Mendoza-Hernández, Ivis, Fernandez-Castillo, Sonsire, Climent-Ruiz, Yanet, Santana-Mederos, Darielys, Ramírez Gonzalez, Ubel, García-Vega, Yanelda, Pérez-Massón, Beatriz, Guang-Wu-Chen, Boggiano-Ayo, Tammy, Ojito-Magaz, Eduardo, Rivera, Daniel G., Valdés-Balbín, Yury, García-Rivera, Dagmar, Vérez-Bencomo, Vicente, Gómez-Maceo, Yanet, Reyes-Matienzo, Radamet, Manuel Coviella-Artime, José, Morffi-Cinta, Irania, Martínez-Pérez, Marisel, Castillo-Quintana, Ismavy, Garcés-Hechavarría, Aniurka, Valera-Fernández, Rodrigo, Martínez-Bedoya, Dayle, Garrido-Arteaga, Raine, Cardoso-SanJorge, Félix, Quintero Moreno, Lauren, Ontivero-Pino, Ivis, Teresa Pérez-Guevara, María, Morales-García, Marilin, Noa-Romero, Enrique, Orosa-Vázquez, Ivette, Díaz-Hernández, Marianniz, Rojas, Gertrudis, Tundidor, Yaima, García-López, Elena, Muñoz-Morejon, Yaima, Galano-Frutos, Evelyn, Rodríguez-Alvarez, Julián, Arteaga, Amaylid, Medina Nápoles, Maite, Espi Ávila, Jennifer, Fontanies Fernández, Marcos
Publicado 2022